Newspaper article from our research archive:

Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts.

Monogram Biosciences, Inc. (South San francisco, CA) has signed an agreement with AVEXA Limited (Melbourne, Australia) to be the exclusive provider of HIV resistance and tropism testing technology in support of Avexa's drug discovery and development programs.

Avexa plans to use Monogram's assays across its virology portfolio, including the phase III program for its lead compound, apricitabine (ATC), an anti-HIV drug in the nucleoside reverse transcriptase inhibitor class. ATC has successfully completed the 48 week dosing of its Phase 2b trial and the Phase 3 program has been initiated. Avexa plans to use Monogram's PhenoSense GT assay to select patients and optimize ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!